Richard W Birkinshaw

15PUBLICATIONS
89CO-AUTHORS
Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 05, 2025
Computational design of potent and selective binders of BAK and BAX.

Stephanie Berger, Erinna F Lee, Tiffany J Harris

|Apr 03, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.

Stefanie M Bader, Dale J Calleja, Shane M Devine

|Mar 05, 2025
Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.

Kaiming Li, Yu Q Yap, Donia M Moujalled

|May 02, 2024
Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.

Zheng Yuan, Mark F van Delft, Mark Xiang Li

|Mar 13, 2022
Structure of the BAK-activating antibody 7D10 bound to BAK reveals an unexpected role for the α1-α2 loop in BAK activation.

Adeline Y Robin, Michelle S Miller, Sweta Iyer

Pageof 3